GSK plc Logo

GSK plc

Develops specialty medicines and vaccines to prevent and treat a range of global diseases.

GSK | US

Overview

Corporate Details

ISIN(s):
GB0009252882
LEI:
Country:
United States of America
Address:
79 NEW OXFORD STREET, 0 LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company researches, develops, and manufactures a portfolio of specialty medicines and vaccines. Its primary R&D is concentrated in four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Leveraging advancements in immunology and human genetics, GSK aims to deliver transformative treatments. The company is also committed to expanding global health access by making its products more affordable and available through strategic partnerships and responsible pricing programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:10
Foreign Filer Report
6-K - GSK plc (0001131399) (Filer)
English 62.0 KB

Automate Your Workflow. Get a real-time feed of all GSK plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GSK plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GSK plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.
South Korea 322970
MORISHITA JINTAN CO.,LTD. Logo
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan 4524
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885
MUSTANG BIO, INC. Logo
Developing CAR T-cell and gene therapies for cancers and rare genetic disorders.
United States of America MBIO
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes prescription & OTC medicines for global markets.
South Korea 017180
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanobiotix Logo
Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.
France NANO
Nanobiotix S.A. Logo
Developing a nanotherapeutic radioenhancer that amplifies radiation to destroy solid tumors.
United States of America NBTX
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland NNG

Talk to a Data Expert

Have a question? We'll get back to you promptly.